Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Brii Biosciences Limited

Clinical trials sponsored by Brii Biosciences Limited, explained in plain language.

Brii Biosciences Limited 2137 HKEX

Biopharmaceutical company developing therapies for infectious diseases and CNS disorders.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

New combo aims to clear hepatitis b virus in 86-Patient trial

Disease control Ongoing

This phase 2 study tests whether adding the experimental drug BRII-835 to standard pegylated interferon can help people with chronic hepatitis B lose the virus surface antigen (HBsAg), a key marker of infection. Eighty-six adults on stable antiviral therapy will receive either in…

Phase: PHASE2 • Sponsor: Brii Biosciences Limited • Aim: Disease control

Last updated Jun 26, 2026 13:27 UTC